Unresectable Intrahepatic Cholangiocarcinoma

12 clinical trials · Condition

Record	Firm	Date
Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver (NCT04175912)	National Cancer Institute (NCI)	2020-03-16
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer (NCT03942328)	Mayo Clinic	2019-09-19
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers (NCT03768414)	SWOG Cancer Research Network	2019-02-07
A Trial of Systemic Chemotherapy in Combination With Conventional Transarterial Chemoembolization in Patients With Advanced Intra-Hepatic Cholangiocarcinoma (NCT02994251)	Yale University	2017-06-21
A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma (NCT02256982)	Massachusetts General Hospital	2014-10-01
Drug-Eluting Bead, Irinotecan Therapy for Unresectable Intrahepatic Cholangiocarcinoma w/Concomitant Gemcitabine and Cisplatin or Carboplatin (NCT01648023)	Robert C. Martin	2012-07-01

Every clearance here is in the API, with alerts when new ones post.